Cargando…

A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity

INTRODUCTION: Stroke is the most disabling neurological disorder and often causes spasticity. Transmucosal cannabinoids (tetrahydrocannabinol and cannabidiol (THC:CBD), Sativex) is currently available to treat spasticity-associated symptoms in patients with multiple sclerosis. Cannabinoids are being...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marinelli, Lucio, Balestrino, Maurizio, Mori, Laura, Puce, Luca, Rosa, Gian Marco, Giorello, Laura, Currà, Antonio, Fattapposta, Francesco, Serrati, Carlo, Gandolfo, Carlo, Abbruzzese, Giovanni, Trompetto, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595207/ https://www.ncbi.nlm.nih.gov/pubmed/28882919 http://dx.doi.org/10.1136/bmjopen-2017-016843

Ejemplares similares

The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray)
por: Grimaldi, Alessandro Enrico, et al.
Publicado: (2019)

The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis‐related spasticity
por: Celius, Elisabeth G., et al.
Publicado: (2018)

A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain
por: Überall, Michael A
Publicado: (2020)

Variability of Multiple Sclerosis Spasticity Symptoms in Response to THC:CBD Oromucosal Spray: Tracking Cases through Clinical Scales and Video Recordings
por: Flachenecker, Peter, et al.
Publicado: (2018)

An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex(®) (THC:CBD, nabiximols) oromucosal spray
por: Etges, Tilden, et al.
Publicado: (2016)

Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry
por: Ueberall, Michael A, et al.
Publicado: (2022)

Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry
por: Ueberall, Michael A, et al.
Publicado: (2019)

Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)
por: Meyer, Thomas, et al.
Publicado: (2019)

Cannabinoid Effect and Safety in Spasticity Following Stroke: A Double-Blind Randomized Placebo-Controlled Study
por: Marinelli, Lucio, et al.
Publicado: (2022)

Spasticity, spastic dystonia, and static stretch reflex in hypertonic muscles of patients with multiple sclerosis
por: Puce, Luca, et al.
Publicado: (2021)

Pathophysiology of Spasticity: Implications for Neurorehabilitation
por: Trompetto, Carlo, et al.
Publicado: (2014)

Differential inflammatory profile in the lungs of mice exposed to cannabis smoke with varying THC:CBD ratio
por: Haidar, Zahraa, et al.
Publicado: (2023)

Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD Cannabis Herbal Extract in Dogs
por: Chicoine, Alan, et al.
Publicado: (2020)

Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study
por: Rosa, Gian Marco, et al.
Publicado: (2022)

Learning “How to Learn”: Super Declarative Motor Learning Is Impaired in Parkinson's Disease
por: Marinelli, Lucio, et al.
Publicado: (2017)

Effectiveness of Botulinum Toxin on Pain in Stroke Patients Suffering from Upper Limb Spastic Dystonia
por: Trompetto, Carlo, et al.
Publicado: (2022)

Manual Linear Movements to Assess Spasticity in a Clinical Setting
por: Marinelli, Lucio, et al.
Publicado: (2013)

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
por: Patti, F, et al.
Publicado: (2016)

Shock Waves in the Treatment of Muscle Hypertonia and Dystonia
por: Mori, Laura, et al.
Publicado: (2014)

A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers
por: Stott, Colin, et al.
Publicado: (2013)

Balance Dysfunction in Parkinson's Disease
por: Rinalduzzi, Steno, et al.
Publicado: (2015)

Dual task gait deteriorates gait performance in cervical dystonia patients: a pilot study
por: Crisafulli, Oscar, et al.
Publicado: (2021)

The Effect of Verbal Encouragement on Performance and Muscle Fatigue in Swimming
por: Puce, Luca, et al.
Publicado: (2022)

Shear wave elastography combined with electromyography to assess the effect of botulinum toxin on spastic dystonia following stroke: A pilot study
por: Campanella, William, et al.
Publicado: (2022)

CBD, a precursor of THC in e-cigarettes
por: Czégény, Zsuzsanna, et al.
Publicado: (2021)

Habituation of Somatosensory Evoked Potentials in Patients with Alzheimer’s Disease and Those with Vascular Dementia
por: Currà, Antonio, et al.
Publicado: (2021)

Rapid In Situ Detection of THC and CBD in Cannabis sativa L. by 1064 nm Raman Spectroscopy
por: Porcu, Stefania, et al.
Publicado: (2022)

Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats
por: Gabaglio, Marina, et al.
Publicado: (2021)

In vivo non-invasive near-infrared spectroscopy distinguishes normal, post-stroke, and botulinum toxin treated human muscles
por: Currà, Antonio, et al.
Publicado: (2021)

Near-Infrared Transflectance Spectroscopy Discriminates Solutions Containing Two Commercial Formulations of Botulinum Toxin Type A Diluted at Recommended Volumes for Clinical Reconstitution
por: Currà, Antonio, et al.
Publicado: (2022)

A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation
por: Solowij, Nadia, et al.
Publicado: (2014)

Protocol for the study of self-perceived psychological and emotional well-being of young Paralympic athletes
por: Puce, Luca, et al.
Publicado: (2017)

The Impact of THC and CBD in Schizophrenia: A Systematic Review
por: Ahmed, Saeed, et al.
Publicado: (2021)

Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience
por: D’hooghe, Marie, et al.
Publicado: (2021)

Effects of Cerebellar tDCS on Inhibitory Control: Evidence from a Go/NoGo Task
por: Mannarelli, Daniela, et al.
Publicado: (2020)

The Ventricular System Enlarges Abnormally in the Seventies, Earlier in Men, and First in the Frontal Horn: A Study Based on More Than 3,000 Scans
por: Currà, Antonio, et al.
Publicado: (2019)

THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
por: Pintori, Nicholas, et al.
Publicado: (2023)

Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Rinalduzzi, Steno, et al.
Publicado: (2016)

A dataset of visible – short wave infrared reflectance spectra collected in–vivo on the dorsal and ventral aspect of arms
por: Currà, Antonio, et al.
Publicado: (2020)

Rapid Distinction and Semiquantitative Analysis of THC and CBD by Silver-Impregnated Paper Spray Mass Spectrometry
por: Huang, Si, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5a0789avinnr2j0u4utc2jpevv